IV Ketamine therapy is used for the treatment of certain mental health conditions, including but not limited to depression, anxiety, post-traumatic stress disorder (PTSD), and chronic pain. Ketamine is a dissociative anesthetic with rapid-acting antidepressant properties, and its use for mental health conditions is an off-label application. The ketamine is administered through IV and the patient will stay for 60+ minutes for monitoring.
Spravato is a prescription nasal spray treatment for treatment-resistant depression. It contains esketamine, a fast-acting form of ketamine. Spravato targets the brain’s glutamate system to relieve depression symptoms quickly—often within 24 hours. It is administered in the clinic, under supervision. Patients stay for 2 hours for monitoring.
Traditional antidepressants can take 4–6 weeks to kick in. Ketamine can start relieving symptoms in hours to a few days, especially for suicidal thoughts. While most antidepressants work on serotonin, norepinephrine, or dopamine, ketamine works on glutamate, the brain’s most common excitatory neurotransmitter, which influences neuroplasticity (your brain’s ability to form new connections). Depression can reduce synaptic connections in the brain. Ketamine may help rebuild those pathways, improving mood and cognitive function.
PTSD often traps the brain in a cycle of fear, hypervigilance, and intrusive memories. Ketamine may help “reset” the brain by weakening those rigid thought loops and reducing the emotional charge tied to traumatic memories. Ketamine enhances the brain’s ability to form new connections, which supports healing and learning in therapy. This makes talk therapy more effective after ketamine sessions. Some patients feel relief within hours to days, especially from flashbacks, nightmares, emotional numbness and suicidal thoughts. Although dissociation is a side effect in some, ketamine can paradoxically reduce chronic dissociation in PTSD sufferers by reconnecting them with the present moment.
Anxiety is often driven by hyperactive brain circuits, especially in areas like the amygdala. Ketamine helps “turn down the volume” on those fear responses and helps your brain process stress differently. Unlike traditional meds that take weeks, ketamine can reduce anxiety within hours to days, especially during acute episodes or intense periods of distress. It promotes the growth of new neural connections, which can help people unlearn anxious habits and thought patterns, respond more flexibly to stress, and make faster progress in therapy. Many patients report reduced: racing thoughts, tight chest or shortness of breath, restlessness or panic, and social avoidance.
Ketamine is an NMDA receptor antagonist, which helps lessen the overactive pain signals sent through your nervous system—kind of like resetting a jammed pain dial. In many chronic pain conditions, the brain and spinal cord become overly sensitive to pain. Ketamine can desensitize those pathways, giving lasting relief even after treatment ends. It also has anti-inflammatory properties and can interrupt pain at multiple levels—from nerve endings to the brain itself. Chronic pain and depression/anxiety often go hand in hand. Since ketamine also boosts mood and reduces emotional suffering, it can help people cope better with their pain, making it feel less overwhelming.
Chronic migraines may “sensitize” the nervous system, making it overreact to triggers. Ketamine can help desensitize those pathways, offering relief where other medications fail. By doing this, it can reduce the intensity and frequency of migraine attacks. IV ketamine has been used in hospital settings as an abortive treatment for intractable migraine attacks—often relieving pain within hours, even for people in status migrainosus (a migraine that lasts for days). Because migraines are often worsened by anxiety, depression, and stress, ketamine’s mood-stabilizing effects can indirectly help reduce the frequency or severity of migraines.
© 2025 Copyright Tennessee Ketamine & Therapeutics
